DHA induces the dephosphorylation of GSK-3β, which results in the downregulation of β-catenin and TCF/LEF, and eventually, in the reduction in cell growth in hepatocellular carcinoma cells [37,38]. Here, GSK3B is linked to hepatocellular carcinoma.